Libri Oncologici

University Hospital for Tumors

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

Libri Oncologici is an open-access journal published by University Hospital for Tumors in Croatia, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 12 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
University Hospital for Tumors
ISSN
0300-8142 · 2584-3826
Country
Croatia
Languages
english
Access
Open access
Articles in DOAJ
127
Declared review time
12 weeks
Declared peer-review model
double_blind

Index listings

  • DOAJ · 2020-11-04
Indexing
DOAJ
APC
—
Declared review time (DOAJ)
12 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

127

Most recent article

8 months ago

Average review time (journal-declared via DOAJ)

12weeks

Works in OpenAlex

217

Last recorded publication year

2025

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

5

i10-index

0

From OpenAlex open data (CC0).

Editorial & policy7
Added to DOAJ
2020-11-04
Declared plagiarism screening
Not declared
Other fees beyond APC
No
Editorial board
Official page ↗
Open references deposited at Crossref
0%
ORCID iDs in current deposits
8%
Peer-review policy
View policy
Identity & continuity1
Source type
journal
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

LCC codes

RC254-282

Subject areas

  • Breast Cancer Treatment Studies
  • Breast Cancer Treatment Studies
  • Breast Cancer Treatment Studies
  • Breast Lesions and Carcinomas
  • Endometrial and Cervical Cancer Treatments
  • Colorectal Cancer Surgical Treatments
  • Ovarian cancer diagnosis and treatment
  • Cancer Immunotherapy and Biomarkers
Show all subjects (75)
  • Colorectal Cancer Screening and Detection
  • MRI in cancer diagnosis
  • Ovarian cancer diagnosis and treatment
  • Ovarian cancer diagnosis and treatment
  • Cancer Diagnosis and Treatment
  • Cancer Diagnosis and Treatment
  • Gastric Cancer Management and Outcomes
  • Cancer Treatment and Pharmacology
  • Cancer Treatment and Pharmacology
  • Gastric Cancer Management and Outcomes
  • Advanced Radiotherapy Techniques
  • Colorectal Cancer Treatments and Studies
  • Cancer survivorship and care
  • Advances in Oncology and Radiotherapy
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer Risks and Factors
  • HER2/EGFR in Cancer Research
  • Global Cancer Incidence and Screening
  • HER2/EGFR in Cancer Research
  • Advances in Oncology and Radiotherapy
  • Cancer Immunotherapy and Biomarkers
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer Immunotherapy and Biomarkers
  • Head and Neck Cancer Studies
  • Cancer Risks and Factors
  • Gastric Cancer Management and Outcomes
  • Inflammatory Biomarkers in Disease Prognosis
  • Palliative and Oncologic Care
  • Bladder and Urothelial Cancer Treatments
  • Immunotherapy and Immune Responses
  • Cancer Risks and Factors
  • Intraperitoneal and Appendiceal Malignancies
  • BRCA gene mutations in cancer
  • Colorectal Cancer Surgical Treatments
  • Colorectal Cancer Surgical Treatments
  • Women's cancer prevention and management
  • Breast Lesions and Carcinomas
  • Global Cancer Incidence and Screening
  • HER2/EGFR in Cancer Research
  • Breast Lesions and Carcinomas
  • Metastasis and carcinoma case studies
  • Metastasis and carcinoma case studies
  • Global Cancer Incidence and Screening
  • Metastasis and carcinoma case studies
  • Cervical Cancer and HPV Research
  • Multiple and Secondary Primary Cancers
  • Advanced Radiotherapy Techniques
  • Cancer, Lipids, and Metabolism
  • Advanced Breast Cancer Therapies
  • Colorectal Cancer Screening and Detection
  • Immunotherapy and Immune Responses
  • Cancer survivorship and care
  • Colorectal Cancer Screening and Detection
  • Cancer survivorship and care
  • Advanced Breast Cancer Therapies
  • Multiple and Secondary Primary Cancers
  • Advanced Radiotherapy Techniques
  • Cancer, Lipids, and Metabolism
  • Immunotherapy and Immune Responses
  • Cervical Cancer and HPV Research
  • Endometrial and Cervical Cancer Treatments
  • Endometrial and Cervical Cancer Treatments
  • Cervical Cancer and HPV Research
  • Renal cell carcinoma treatment
  • Cutaneous Melanoma Detection and Management
  • Renal cell carcinoma treatment
  • Cutaneous Melanoma Detection and Management

Keywords (DOAJ)

  • clinical oncology
  • surgical oncology
  • radiotherapy
  • support therapy
  • neoplasms
  • malignant disease

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: